VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 05, 2024 11:49am

72 Views

Post# 36119801

Interesting comment of Hugh on this post and 👀 Dr.Theodore

Interesting comment of Hugh on this post and Dr.Theodore Abraham Dr. Abraham earned his medical degree from Goa Medical College at the University of Bombay. He completed an internal medicine residency and an echocardiography research fellowship at Wake Forest University in Winston-Salem, N.C. Dr. Abraham then completed fellowships in clinical cardiology and echocardiography at the University of Texas Southwestern Medical Center in Dallas, Texas, and advanced echocardiography and muscle physiology at the Mayo Clinic in Rochester, Minn. After previous appointments at Mayo Clinic and Johns Hopkins University, he is currently a cardiologist and Meyer Friedman Distinguished Professor at the University of California San Francisco, where he also serves as the institution’s Adult Cardiac Echocardiography Laboratory Director and HCM Center of Excellence Co-director.

The American Society of Echocardiography is pleased to announce the appointment of Theodore Abraham, MD, FASE, as the organization’s new President, effective July 1, 2024.

Read our press release: bit.ly/4cNB7R7